The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation
Kyriaki Tzogani, Hilde Røshol, Helga Haugom Olsen, Ida B Aas, Marianne Løiten Dalhus, Gro Dahlseng Håkonsen, Laila Sortvik Nilssen, Vibeke Lindberg, Mats Økvist, Bjørg Bolstad, Irēna Rogovska, Natalja Karpova, Harald Enzmann, Christian Gisselbrecht, Francesco Pignatti
Research output: Contribution to journal › Review article › peer-review
11Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation'. Together they form a unique fingerprint.